Ebola Vaccine Approved in Europe in Landmark Moment in Fight Against a Deadly Disease

November 11, 2019

(STAT News) – After more than two decades of research, the world finally has an approved Ebola vaccine. The European Commission granted marketing authorization to Merck’s vaccine, known as Ervebo, on Monday, less than a month after the European Medicines Agency recommended it be licensed. Previously, the vaccine has been used only in clinical trials.